Cboe BZX · EDGEHealthcarePharmaceuticals

MRBL Enhanced Equity ETF (EDGE)

$51.97−0.54%
Close Sep 28, 2026 · split-adjusted
Sep 28, 2026$51.97▲ 20.57% in range
Sep 29, 2025Low $42.20 · High $52.33Sep 28, 2026
What changed · written from our data
As of Sep 28, 2026

MRBL Enhanced Equity ETF closed at $51.97 on Sep 28, down 0.54%, 0.7% below its 52-week closing high. Volume of 238 shares was 0.52× its 20-day average (below normal).

Split-adjusted performance: -0.3% over one month, +22.6% over six months, +21.7% over one year.

Short interest was 1.1K shares at the Sep 15 settlement, down 88.6% from the prior report (4.4 days to cover).

Market cap$12.5M240.0K shares
Revenue · quarter$0.00—
Diluted EPS$-0.18—
P/E · TTM—
Net margin—
Dividend yieldNone
52-week range42.20 – 52.33−0.7% from high
Volume2380.52× 20-day avg
Volatility · 60d10.7%Annualised
Short % of float—4.4 days to cover
Net cash$1.2MCash $5.6M
Next earnings—Not scheduled
Split-adjusted performance
1W −0.5%1M −0.3%3M +5.3%6M +22.6%YTD +14.5%1Y +21.7%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 423 companies (100 = best)

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Industry medians: 6-month return −2.9%, revenue growth +6.4%, net margin −42.6%, P/E 16.2×.

Short interest

Details →
Shares short1.1K−88.6% vs prior
Days to cover4.4Settled Sep 15
% of float—
Short vol. 10d63.5%of daily volume

Closest peers by size in Pharmaceuticals

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
EDGEMRBL Enhanced Equity ETF$51.97−0.54%+22.6%———$12.5M
EYEGAB Corporate Bond ETF$33.45−0.61%−4.2%———$26.8MCompare
CPSRCalamos S&P 500 Structured Alt Protection ETF - March$26.19+0.03%+3.9%−87.7%−693.9%—$34.0MCompare
UNOVInnovator U.S. Equity Ultra Buffer ETF - November$41.36−0.24%+12.4%+3.0%8.0%27.4$106.5MCompare

News about MRBL Enhanced Equity ETF

All news →

No recent articles focused on MRBL Enhanced Equity ETF. 2 articles mention it in passing.

Quick answers

What is EDGE's market cap?
$12.47M, based on the Sep 28 close of $51.97.
What sector is EDGE in?
Healthcare, in the Pharmaceuticals industry.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology